Announcement on Changes in the Company's Accounting Policy
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2020-020
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Changes in Company Accounting Policies
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Note:
● The implementation of the new revenue standard by the Company will not result in significant changes in the Company's revenue recognition method and will not affect the Company's financial position, operating results and cash flow, including total assets, net assets and net profit.
1. the basic information of this accounting policy change
(1 ) Overview of accounting policy change
2017 7 5 , the Ministry of Finance issued the "Notice on Revising and Issuing < Enterprise Accounting Standards 14 - Income > " (Accounting [2017 ] 22 ) (hereinafter referred to as "New Income Standards " ), enterprises that are required to be listed at the same time at home and abroad and enterprises that are listed abroad and adopt International Financial Reporting Standards or Enterprise Accounting Standards to prepare financial statements shall come into effect from 2018 1 ; Other domestic listed enterprises shall come into effect from 2020 1 1 ; non-listed companies that implement corporate accounting standards, effective from 2021 1 February 1 . In accordance with the requirements of this document, the Company has made changes to the contents of the relevant accounting policies, which will take effect from 2020 1 1 .
(2 ) Board of Directors Review
2020 August# July 28 , the company held the 10th Board of Directors st meeting by means of communication voting. All the existing eight directors of the company attended the meeting. After review and voting, the Board of Directors approved the "Bill on Changes in the Company's Accounting Policy" with 8 votes in favor, 0 votes against, and 0 abstentions.
(3) Review of the Board of Supervisors
2020August April 28 , the company held the 10thth meeting of the 9th Board of Supervisors by means of communication voting. All the existing five supervisors of the company attended the meeting. After review and voting, with 5 votes in favor, 0 votes against, 0 abstentions, the board of supervisors deliberated and passed the "bill on the change of accounting policy of the company". 2. the specific contents of this accounting policy change
The specific contents of the new income standard change are as follows
:1
, bringing the current income and construction contract standards into a unified income recognition model;2
, replacing risk-reward transfer with control transfer as the judgment standard of income recognition time point;3
, provides clearer guidance on the accounting treatment of contracts containing multiple trading arrangements;4
, provides clear provisions on revenue recognition and measurement for certain specific transactions (or event ) .
Impact of Changes in 3. Accounting Policy on the Company
The Company has implemented the new income standard since January 132
, January 13, March, 135, According to the requirements stipulated in the convergence of the new income standard, the Company will not adjust the information for comparable periods. The implementation of the new revenue standard will not result in significant changes in the way the Company recognizes revenue, will not affect the Company's financial position, results of operations and cash flows, including total assets, net assets and net profit, and will not be detrimental to the interests of the Company and its shareholders. Concluding Opinions of Independent Directors and Supervisors of 4.
Independent Directors of (I)Independent Directors believe that the company's accounting policy change is a reasonable change in accordance with the requirements of relevant documents of the Ministry of Finance and conforms to the relevant regulations of the Ministry of Finance, China Securities Regulatory Commission and Shanghai
Stock Exchange
and other regulatory agencies, the implementation of the changed accounting policy can objectively and fairly reflect the company's financial position and operating results. The review and decision-making process of this accounting policy change is 148 in compliance with the relevant laws and regulations and the Articles of Association of the Company, and will not have a significant impact on the Company's financial position, operating results and cash flow, and the 150 does not harm the interests of the Company and all shareholders.Opinions of the Board of Supervisors of the (II)
The Board of Supervisors believes that the change in the company's accounting policy complies with the relevant provisions of the Accounting Standards for Business Enterprises, can objectively and fairly reflect the company's financial status and operating results, and there is no harm to the company's interests and small and medium-sized The situation of the legitimate rights and interests of shareholders. Its decision-making procedures comply with the relevant laws and regulations and the provisions of the Articles of Association. We agree to this change in the Company's accounting policy.
filing document(I) the resolution of the 16th meeting of the 10th board of directors of the company;
Resolution of the 10th Meeting of the 9th Board of Supervisors of the (II);
Independent Opinions of (III) Independent Directors on Changes in Accounting Policies
This is to announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
August 29, 2002
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page